| S.No. | Chemical Name of the Intermediate | CAS No. | Related to API | Therapeutic category |
|---|---|---|---|---|
| 1 | 5-bromo-2-chloro-4'-ethoxydiphenylmethane | 461432-23-5 | Dapagliflozin | Anti Diabetic |
| 2 | 5-bromo-2-chlorophenyl)(4-ethoxyphenyl) methanone | 461432-22-4 | ||
| 3 | 2,3,4,6-Tetrakis-O-trimethylsilyl-Dgluconolactone | 32384-65-9 | ||
| 4 | Methyl 1-C- [4-chloro-3- [(4-ethoxyphenyl) methyl] phenyl]-alpha-D-gluco pyranoside | 714269-57-5 | ||
| 5 | (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4ethoxyphenyl)methyl]phenyl]-D-glucitol tetra acetate | 461432-25-7 | ||
| 6 | 3-(3-Chloropropyl)-1,3-dihydro-7, 8-dimethoxy- 2H-3-benzazepin-2-one | 85175-59-3 | Ivabradine HCl | Cardio vascular |
| 7 | 1,3-Dihydro-3- (3-iodopropyl)-7,8-dimethoxy- 2H-3-benzazepin-2-one | 148870-57-9 | ||
| 8 | [(S)-3-(3-(((3,4-dimethoxy bicyclo [4.2.0] octa-1 (6), 2,4-trien-7-yl) methyl) (methyl) amino) propyl)-7,8-dimethoxy-1, 3-dihydro-2H-benzo[d] `azepin-2-one] | 1086026-31-4 | ||
| 9 | 4-(4-chlorophenyl)-1H-benzo[d][1,2] oxazin-1one | 2224-83-1 | Chlorthalidone | Cardio vascular |
| 10 | 3-(4-chlorophenyl) isoindolin-1-one | 2224-77-3 | ||
| 11 | 2-Chloro-5- (2,3-dihydro-3-oxo-1H-isoindol-1yl)-benzene sulfonamide | 82875-49-8 | ||
| 12 | 2-Chloro-3, 4-dihydroxyacetophenone | 99-40-1 | Isoproterenol HCl | Cardio vascular |
| 13 | 1-(3,4-dihydroxyphenyl)-2-(isopropyl amino) ethan-1-one Hydrochloride | 16899-81-3 | ||
| 14 | (3R, 4S, 5R)-2-(6-amino-2-chloro-9H-purin-9yl)-5-(hydroxymethyl) tetrahydrofuran-3, 4-diol | 146-77-0 | Regadenoson | Contrast Agent |
| 15 | (3R, 4S, 5R)-2-(6-amino-2-hydrazinyl-9H-purin-9-yl)-5-(hydroxymethyl) tetrahydrofuran-3,4-diol | 15763-11-8 | ||
| 16 | Ethyl1- (6-amino-9- ((3R, 4S, 5R)-3,4dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2yl)-9H-purin-2-yl)-1H-pyrazole-4-carboxylate | 313348-29-7 | ||
| 17 | 1-(6-amino-9- ((3R, 4S, 5R)-3,4-dihydroxy-5 (hydroxymethyl) tetrahydrofuran-2-yl)-9H-purin2-yl)-1H-pyrazole-4-carboxylic acid | 313348-16-2 | ||
| 18 | Phenyl Hydrazine Hydrochloride | 59-88-1 | Edaravone | To treat Amyotrophic Lateral Sclerosis |
| 19 | 1-(7,8-diamino-1, 2,4,5-tetrahydro-3H-1, 5methanobenzo [d] azepin-3-yl)-2,2,2trifluoroethan-1-one | 230615-69-7 | Varenicline Tartrate | Smoking cessation |
| 20 | 2,2,2-trifluoro-1- (6,7,9,10-tetrahydro-8H-6, 10methanoazepino [4,5-g] quinoxalin-8-yl) ethan-1-one | 230615-70-0 | ||
| 21 | Varenicline Free Base | 249296-44-4 | ||
| 22 | N,N-dimethyl-4-nitrosoaniline Hydrochloride | 42344-05-8 | Methylene Blue | To treat methemoglobinemia |
| 23 | N1,N1-dimethylbenzene-1,4-diamine (DMPPDA) | 99-98-9 | ||
| 24 | 2-Amino-5-dimethylaminophenyl Thiosulphonic acid | 43035-11-6 | ||
| 25 | 2-(3,4-dimethylphenyl)-5-methyl-1, 2-dihydro-3H-pyrazol-3-one | 277299-70-4 | Eltrombopag | Medication for conditions that lead to thrombocytopenia |
| 26 | Eltrombopag Free Acid | 496775-61-2 | ||
| 27 | (2R, 3R)-3-(2,3-dihydrobenzo [b][1,4] dioxin-6yl)-3-hydroxy-2-(((S)-2-hydroxy-1-phenylethyl) amino)-1-(pyrrolidin-1-yl)propan-1-one | 491833-26-2 | Eliglustat Tartrate | Gaucher Disease type-1 |
| 28 | (1R, 2S)-1-(2,3-dihydrobenzo [b][1,4] dioxin-6yl)-2-(((S)-2-hydroxy-1-phenylethyl) amino)-3(pyrrolidin-1-yl) propan-1-ol | 491833-27-3 | ||
| 29 | (1R, 2S)-2-amino-1- (2, 3-dihydrobenzo [b][1,4] dioxin-6-yl)-3-(pyrrolidin-1-yl) propan-1-ol | 491833-28-4 | ||
| 30 | Eliglustat Free Base | 491833-29-5 | ||
| 31 | (2S)-1-[[(2-Amino-1,1-dimethylethyl)amino]acetyl]-2-pyrrolidinecarbonitrile | 794460-89-2 | Anagliptin | Antidiabetic |
| 32 | 2-Methyl-pyrazolo[1,5-a]pyrimidine-6-carboxylic acid | 739364-95-5 | ||
| 33 | 6-amino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione | 6642-31-5 | Theophylline | COPD & Asthma |
| 34 | 6-amino-1,3-dimethyl-5-nitrosopyrimidine-2,4(1H,3H)-dione | 6632-68-4 | ||
| 35 | 5,6-diamino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione | 5440-00-6 | ||
| 36 | N-(5-amino-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)formamide | 7597-60-6 | ||
| 37 | 3-(4-chlorophenyl) propanoic acid | 2019-34-3 | Pitolisant HCl | Narcolepsy with or without cataplexy |
| 38 | 3-(4-chlorophenyl) propan-1-ol | 6282-88-8 | ||
| 39 | 3-(4-chlorophenyl) propyl methane sulfonate | 61440-60-6 | ||
| 40 | 3-(piperidin-1-yl) propan-1-ol | 104-58-5 | ||
| 41 | Sodium 3-(piperidin-1-yl) propan-1-olate | 462115-38-4 | ||
| 42 | 6-amino-1, 3-diethylpyrimidine-2, 4(1H, 3H)dione | 41740-15-2 | Istradefylline | Parkinson's disease |
| 43 | 6-amino-1, 3-diethyl-5-nitrosopyrimidine-2,4(1H, 3H)-dione | 89073-60-9 | ||
| 44 | 5,6-diamino-1, 3-diethylpyrimidine-2, 4(1H,3H)-dione | 1785764-26-2 | ||
| 45 | (E)-3-(3,4-dimethoxyphenyl) acrylic acid | 14737-89-4 | ||
| 46 | (E)-N- (6-amino-1, 3-diethyl-2, 4-dioxo-1, 2,3,4tetrahydropyrimidin-5-yl)-3-(3,4dimethoxyphenyl) acrylamide | 187393-68-6 | ||
| 47 | (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-3, 7dihydro-1H-purine-2, 6-dione | 155270-98-7 | ||
| 48 | ethyl 7-bromo-2,2-dimethylheptanoate | 123469-92-1 | Bempedoic acid | Hypercholesterolemia |
| 49 | diethyl 8-cyano-2,2,14,14-tetramethyl-8-tosylpentadecanedioate | 738606-44-5 | ||
| 50 | diethyl 2,2,14,14-tetramethyl-8-oxopentadecanedioate | 738606-43-4 | ||
| 51 | 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid | 413624-71-2 | ||
| 52 | 2-(benzyl(methyl)amino)acetaldehyde | 166947-11-1 | Revefenacin | Chronic obstructive pulmonary disease (COPD) |
| 53 | 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 743460-48-2 | ||
| 54 | piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 171722-92-2 |